Company intelligence / Profile preview
Kibow Therapeutics
Newtown Square, Pennsylvania, United Stateskibowtx.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Kibow Therapeutics’ lead candidate KT-301/US‑APR2020—a live biotherapeutic consortium of proprietary commensal bacteria—has entered Phase 2b clinical trials in patients with stage 4 CKD. The goal is to validate safety and efficacy in delaying dialysis and improving kidney function by reducing uremic toxins through gut microbiome modulation. About half of the targeted enrollment has been achieved as of recent updates. Preclinical and early clinical data support safety and positive outcomes for renal health; additional studies are planned for ESRD/dialysis populations
- Therapeutic areas
- Nephrology
- Modalities
- Live biotherapeutic product therapyMicrobial therapyProbiotic supplement
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
No major pharmaceutical partnerships disclosed; received SBIR grants from NIDDK-NIH and USAID funding for R&D
Beyond the preview
Go deeper on Kibow Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kibow Therapeutics.